Our study confirms that TNF is significantly elevated in the CSF of MS patients at the time of diagnosis and that soluble TNF-R1 predominates over TNF-R2 even in physiological conditions (5:1 ratio) with a greater overexpression of TNF-R1 in patients compared to controls. The gene discussed is TNF; the disease is myeloid sarcoma.